Vaxil Announces Close of Second and Final Tranche of Previously Announced Non-Brokered Private Placement for Gross Proceeds of $264,100

Ads

You May Also Like

Biocartis Group NV: Results of the extraordinary shareholders’ meeting held on 11 September 2017

PRESS RELEASE: REGULATED INFORMATION11 September 2017, 17:40 CEST                                                            Results of the extraordinary shareholders' meeting ...

Loxo Oncology to Announce Second Quarter 2016 Financial Results

STAMFORD, Conn., July 27, 2016 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical ...